@prefix ns2: .
@prefix this: .
@prefix sub: .
@prefix np: .
@prefix rdf: .
@prefix nt: .
@prefix xsd: .
@prefix rdfs: .
@prefix orcid: .
@prefix bl: .
@prefix nkg: .
@prefix prov: .
@prefix npx: .
sub:Head {
this: a np:Nanopublication;
np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubinfo .
}
sub:assertion {
sub:association a rdf:Statement;
rdf:object ;
rdf:predicate bl:treats;
rdf:subject ;
rdfs:label "Clozapine is indicated for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder who are judged to be at chronic risk for re-experiencing suicidal behavior, based on history and recent clinical state";
bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation;
bl:has_population_context sub:cohort;
bl:provided_by "NeuroDKG";
bl:publications ;
bl:relation nkg:SymptomaticReliefIndication .
sub:cohort rdfs:label "patients (...) who are judged to be at chronic risk for re-experiencing suicidal behavior";
bl:category bl:Cohort .
bl:category bl:Drug .
bl:category bl:Disease .
}
sub:provenance {
sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 .
}
sub:pubinfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB";
npx:hasSignature "DFkf5aQnQ6VDdqsWS7w0BZ4Qzft8Nla1/T3xrbhLTqiIWSKvURWNKYKpx+9aDCKrJUEBlknVjHCKH7tFtctE6C+NxNeEyHBucRDE8usCQPyfKe81nLaVkNIz/Rq86s/0GzmONt3Wq4Pm4/Wb/488uemkr3Pr+FnwNbMF3DazVS0=";
npx:hasSignatureTarget this: .
this: ns2:created "2021-03-23T20:26:20.681+01:00"^^xsd:dateTime;
ns2:creator orcid:0000-0002-1468-3557;
nt:wasCreatedFromProvenanceTemplate ;
nt:wasCreatedFromPubinfoTemplate ;
nt:wasCreatedFromTemplate .
}